long acting Injection [Design Issues]

posted by jag009  – NJ, 2020-04-21 21:06 (161 d 15:13 ago) – Posting: # 21342
Views: 683

Hi,

» But if it is mentioned in monograph that half-life is 17 days following single dose and 46 days after multiple dose, then which half-life we should consider while designing multiple dose study? In the same monograph, it is also stated that steady state is achieved after 4th dose on injection.

Have you found out why the increase in half-life?

J

Complete thread:

Activity
 Admin contact
21,087 posts in 4,398 threads, 1,468 registered users;
online 28 (0 registered, 28 guests [including 4 identified bots]).
Forum time: Wednesday 12:19 CEST (Europe/Vienna)

When puzzled, it never hurts to read the primary documents 
a rather simple and self-evident principle that has, nonetheless,
completely disappeared from large sectors
of the American experience.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5